Previous Chapter: 4 Ethical Issues in Pandemic Planning and Response
Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.

Appendix A
Agenda

Ethical and Legal Considerations in Mitigating Pandemic Disease

PAHO Headquarters—Conference Room A

525 23rd Street, NW

Washington, D.C.

September 19-20, 2006


AGENDA

Tuesday, September 19, 2006

8:30 a.m.

Continental Breakfast

9:00 a.m.

Welcome and Opening Remarks

Stanley M. Lemon, M.D., Chair,

Forum on Microbial Threats

9:15–10:00 a.m.

KEYNOTE ADDRESS: “Past as Prologue?”

David Heymann, M.D.,

World Health Organization

10:00–10:15 a.m.

Discussion

Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.

Session I:
Understanding the Challenges of the Future by Examining the Past: Influenza/Smallpox/SARS

Moderator: Ruth Berkelman, M.D., Emory University,

Rollins School of Public Health


10:15–11:00 a.m.

Contemplating Pandemics: The Role of Historical

Inquiry in Developing Pandemic-Mitigation Strategies for the Twenty-First Century

Howard Markel, M.D., University of Michigan

11:00–11:45 a.m.

The Smallpox Eradication Campaign

D.A. Henderson, M.D., Center for Biosecurity,

University of Pittsburgh Medical Center

11:45 a.m.–12:30 p.m.

Lessons from SARS

David Heymann, M.D., World Health Organization

12:30–1:00 p.m.

Session I Q&A

1:00–1:45 p.m.

LUNCH

Session II:
Domestic, Regional, and International Preparedness Planning

Moderator: P. Frederick Sparling, M.D., Vice Chair,

Forum on Microbial Threats

1:45–2:30 p.m.

U.S. Government Preparedness Plans

Bruce Gellin, M.D., Office of the Secretary,

Department of Health and Human Services

2:30–3:15 p.m.

Regional Planning Efforts

Oscar J. Mujica, M.D., M.P.H., P.H.E.,

Pan American Health Organization

3:15–3:45 p.m.

Q&A

3:45–4:00 p.m.

BREAK

4:00–4:45 p.m.

Ethical Considerations in International Preparedness

Planning Efforts

Alexander Morgan Capron, University of Southern

California

Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.

4:45–5:15 p.m.

Open Discussion of Session II

5:15–6:00 p.m.

Open Discussion of Day 1

6:00 p.m.

Adjourn

Wednesday, September 20, 2006

8:00 a.m.

Continental Breakfast

8:30 a.m.

Opening Remarks/Summary of Day 1:

Margaret A. Hamburg, M.D.,

Vice Chair, Forum on Microbial Threats

Session III:
Disease Mitigation Strategies–Quarantine, Containment and Modeling

Moderator: Gary Roselle, M.D., Program Director for Infectious Diseases,

Department of Veterans Affairs Central Office

8:45–9:30 a.m.

Public Health and Ethical Considerations in

Planning for Quarantine

Martin Cetron, M.D.,

Centers for Disease Control and Prevention

9:30–10:15 a.m.

Preparing for Pandemic Influenza:

Legal and Ethical Challenges

Lawrence Gostin, J.D.,

Georgetown University School of Law

10:15–10:30 a.m.

Discussion

10:30–11:15 a.m.

The Role of Modeling in Infectious Disease

Mitigation and Containment

Joshua Epstein, Ph.D., The Brookings Institution

11:15–11:45 a.m.

Discussion Panel:

  • Timothy C. Germann, Ph.D., Los Alamos National Laboratory

  • James LeDuc, M.D., Centers for Disease Control and Prevention

  • Victoria Sutton, J.D., Ph.D., Texas Tech University School of Law

Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.

11:45 a.m.–12:30 p.m.

Lunch

12:30–1:30 p.m.

Luncheon Remarks

Harvey V. Fineberg, M.D., Ph.D.,

President, Institute of Medicine

Session IV:
Ethical Issues in Pandemic Planning and Response

Moderator: Stanley M. Lemon, M.D., Chair, Forum on Microbial Threats

1:30–2:15 p.m.

Intensive Care Unit Triage During an Influenza

Pandemic: The Need for Specific Clinical Guidelines

Bernard Lo, M.D.,

University of California, San Francisco

2:15–3:00 p.m.

Social Justice and Pandemic Planning and Response

Ruth Faden, Ph.D.,

Berman Bioethics Institute, Johns Hopkins University

3:00–3:45 p.m.

Discussion Panel:

  • Steven Bice, Battelle, Atlanta, Georgia

  • D.A. Henderson, M.D., Center for Biosecurity, University of Pittsburgh Medical Center

  • Shelley Hearne, D.P.H., Johns Hopkins University

3:45–4:30 p.m.

Open Discussion

4:30–4:45 p.m.

Closing Remarks/Adjourn

Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
Page 203
Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
Page 204
Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
Page 205
Suggested Citation: "Appendix A Agenda." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
Page 206
Next Chapter: Appendix B Acronyms
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.